Parkinson's Disease: A Holistic Approach

American Journal of Nursing

Volumn 98, Issue 11, 1998, Pages

  Barker, Susan ^a   Grant, Amy ^a   Hodnicki, Donna R ^b  

^a MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DAILY LIFE ACTIVITY; DECISION TREE; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHILOSOPHY; REVIEW; RISK FACTOR; SELF HELP;

ACTIVITIES OF DAILY LIVING; ALGORITHMS; DECISION TREES; HOLISTIC HEALTH; HUMANS; PARKINSON DISEASE; RISK FACTORS; SELF-HELP GROUPS;

EID: 0032215425     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.2307/3471688     Document Type: Article

References (27)

1. Olanow, C. W., and Koller, W. C. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines. Neurology 50(3 Suppl. 3):S1-S57, Mar. 1998.
2. Helme, R. D. Movement disorders. IN Manual of Neurologic Therapeutics, 5th ed., edited by M. S. Samuels. Boston, Little, Brown, 1995, pp. 327-353.
3. Lerner, A. J. Parkinson's disease. IN The Little Black Book of Neurology, 3rd ed., edited by A. J. Lerner [et al]. St. Louis, Mosby, 1995, pp. 324-326.
4. Koller, W. C., et al. Relationship of aging to Parkinson's disease. Advance Neurology 45:317-321, 1987.
5. Boss, B. J., et al. Alterations of neurologic function. IN Pathophysiology: The Biological Basis for Disease in Adults and Children, 2nd ed., edited by K. L. McCance and S. E. Huether. St. Louis, Mosby, 1994, pp. 527-623.
6. Koller, W. C. When does Parkinson's disease begin? Neurology 42(4 Suppl. 4):27-31, Apr. 1992.
7. Eldridge, R., and Ince, S. E. The low concordance rate for Parkinson's disease in twins: A possible explanation. Neurology 34:1354-1356, Oct. 1984.
8. Duvoisin, R. C. Genetics of Parkinson's disease. Advance Neurology 45:307-312, 1987.
9. Johnson, W. G., et al. Twin studies and the genetics of Parkinson's diseasea reappraisal. Mov.Disord. 5:187-194, 1990.
10. Jenner, P., et al. New insight into the cause of Parkinson's disease. Neurology 42:2241-2250, Dec. 1992.
11. Koller, W., et al. Environmental risk factors in Parkinson's disease. Neurology 40:1218-1221, Aug. 1990.
12. Duvoisin, R. C. A plethora of symptoms. IN Parkinson's Disease: A Guide for Patient and Family, 3rd ed., by R. C. Duvoisin. New York, Raven Press, 1991, pp. 16-56.
13. Lieberman, A. N., and Williams, F. L. Understanding Parkinson's disease. IN Parkinson's Disease: The Complete Guide for Patients and Caregivers, by A. N. Lieberman and F. L. Williams. New York, Simon & Schuster, 1993, pp. 7-13.
14. Berchou, R. Medication Management for Patients with Parkinson's: A Primer for Clinicians [pamphlet]. Wilmington, DE, DuPont Pharma, 1996.
15. Stern, M. B. Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: An overview. Neurology 49(1 Suppl. 1):S2-S9, July 1997.
16. Olanow, C. W. Oxidation reactions in Parkinson's disease. Neurology 40(10 Suppl. 3):32-37, Oct. 1990.
17. Waters, C. H. Managing the late complications of Parkinsons disease. Neurology 49(1 Suppl. 1):S49-S57, July 1997.
18. Jenner, P., et al. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250, Dec. 1992.
19. Ahlskog, J. E. Treatment of early Parkinson's disease: Are complicated strategies justified? Mayo Clinic Proc. 71:659-670, July 1996.
20. Olanow, C. W. Attempts to obtain neuroprotection in Parkinson's disease. Neurology 49 (1 Suppl. 1):S26-S33, July 1997.
21. Warts, R. L. The role of dopamine agonists in early Parkinson's disease. Neurology 49(1 Suppl. 1):S34-S48, July 1997.
22. Kurth, M. C., et al. Tolcapone improves motor function and reduces levodopa requirements in patients with Parkinson's disease experiencing motor fluctuations: A multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I. Neurology 48:81-87, Jan. 1997.
23. Aminoff, M. J. Treatment of Parkinson's disease. West.J.Med. 161:303-308, Sept. 1994.
24. Waters, C. H., et al. Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment. The Tolcapone Stable Study Group. Neurology 49:665-671, Sept. 1997.
25. Jankovic, J., and Tolosa, E., eds. Parkinson's Disease and Movement Disorders. Baltimore, 3rd ed. Baltimore, Williams & Wilkins, 1998.
26. Uphold, C. R., and Graham, M. V. Parkinson's disease. IN Clinical Guidelines in Family Practice, 2nd ed., by C. R. Uphold and M. V. Graham. Gainesville, FL, Barmarrae Books, 1994, pp. 778-782.
27. Duvoisin, R. C., and Sage, J. Parkinson's Disease: A Guide for Patient and Family, 4th ed. New York, Lippincott-Raven Publishers, 1996.